Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,160
+80 (0.79%)
Mar 27, 2025, 3:30 PM KST

KRX:007570 Revenue

Ilyang Pharmaceutical Co.,Ltd had revenue of 99.14B KRW in the quarter ending September 30, 2024, a decrease of -1.48%. This brings the company's revenue in the last twelve months to 364.56B, down -0.78% year-over-year. In the year 2023, Ilyang Pharmaceutical Co.,Ltd had annual revenue of 370.54B, down -3.46%.

Revenue (ttm)
364.56B
Revenue Growth
-0.78%
P/S Ratio
0.50
Revenue / Employee
572.31M
Employees
637
Market Cap
182.12B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023370.54B-13.27B-3.46%
Dec 31, 2022383.81B12.46B3.36%
Dec 31, 2021371.35B28.02B8.16%
Dec 31, 2020343.33B18.76B5.78%
Dec 31, 2019324.57B24.54B8.18%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,547.32B
Celltrion 3,557.30B
ALTEOGEN 102.85B
Yuhan 2,067.79B
SK Biopharmaceuticals 547.60B
HLB Co., Ltd. 51.92B
Sam Chun Dang Pharm. 210.92B
PharmaResearch 350.12B
Revenue Rankings